Literature DB >> 29406924

White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.

Hideto Joki1, Yuichi Higashiyama1, Yoshiharu Nakae1, Chiharu Kugimoto1, Hiroshi Doi1, Katsuo Kimura2, Hitaru Kishida2, Naohisa Ueda2, Tatsu Nakano3, Tatsuya Takahashi4, Shigeru Koyano1, Hideyuki Takeuchi1, Fumiaki Tanaka5.   

Abstract

BACKGROUND: In dementia with Lewy bodies (DLB) and Parkinson's disease with dementia (PDD), it is still debated whether white matter hyperintensities (WMH) on MRI reflect atherosclerotic cerebrovascular changes or Alzheimer's disease (AD)-related pathology such as cerebral amyloid angiopathy. To examine AD-related pathology in DLB and PDD, we compared the severity of WMH and medial temporal lobe atrophy among patients with DLB, PDD, non-demented PD (PDND), and AD.
METHODS: We retrospectively studied sex- and age-matched outpatients with AD, DLB, PDD, and PDND, as well as subjects without central nervous system disorders as normal controls (n=50 each). All subjects underwent 1.5-T MRI examinations, and WMH detected by T2-weighted images or fluid-attenuated inversion recovery images were semiquantified according to the Fazekas method. Medial temporal lobe atrophy (MTA) was visually assessed by the MTA score.
RESULTS: WMH were more prominent in AD, DLB, and PDD patients than in PDND patients and normal controls (NCs). DLB as well as AD showed more severe WMH than PDD. Visual assessment of medial temporal lobe atrophy showed that AD patients had the most severe atrophy, followed by DLB, PDD, and PDND patients, and NC subjects in that order. MTA scores showed significant correlations with WMH severity.
CONCLUSION: Our results indicated that DLB was more similar to AD than to PDD in terms of MRI findings, suggesting that WMH in DLB may reflect mainly AD-related pathology rather than atherosclerotic cerebrovascular changes.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Dementia with Lewy bodies; MRI; Medial temporal lobe atrophy; Parkinson's disease with dementia; White matter hyperintensities

Mesh:

Year:  2017        PMID: 29406924     DOI: 10.1016/j.jns.2017.12.018

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  20 in total

Review 1.  Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2017-12-08       Impact factor: 3.575

2.  Significance of cerebral amyloid angiopathy and other co-morbidities in Lewy body diseases.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2021-04-29       Impact factor: 3.575

Review 3.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

4.  Translating state-of-the-art brain magnetic resonance imaging (MRI) techniques into clinical practice: multimodal MRI differentiates dementia subtypes in a traditional clinical setting.

Authors:  Taylor Kuhn; Sergio Becerra; John Duncan; Norman Spivak; Bianca Huan Dang; Barshen Habelhah; Kennedy D Mahdavi; Michael Mamoun; Michael Whitney; F Scott Pereles; Alexander Bystritsky; Sheldon E Jordan
Journal:  Quant Imaging Med Surg       Date:  2021-09

5.  Differential spatial distribution of white matter lesions in Parkinson's and Alzheimer's diseases and cognitive sequelae.

Authors:  Michael T Grey; Kristína Mitterová; Martin Gajdoš; Richard Uher; Patrícia Klobušiaková; Irena Rektorová; Ivan Rektor
Journal:  J Neural Transm (Vienna)       Date:  2022-07-11       Impact factor: 3.850

Review 6.  Differentiating dementia with Lewy bodies from Alzheimer's disease and Parkinson's disease dementia: an update on imaging modalities.

Authors:  Rotem Iris Orad; Tamara Shiner
Journal:  J Neurol       Date:  2021-01-29       Impact factor: 4.849

Review 7.  Molecular and Clinical Issues about the Risk of Venous Thromboembolism in Older Patients: A Focus on Parkinson's Disease and Parkinsonism.

Authors:  Claudio Tana; Fulvio Lauretani; Andrea Ticinesi; Beatrice Prati; Antonio Nouvenne; Tiziana Meschi
Journal:  Int J Mol Sci       Date:  2018-04-26       Impact factor: 5.923

8.  Volume of white matter hyperintensities increases with blood pressure in patients with hypertension.

Authors:  Yu Zhao; Zunyu Ke; Wenbo He; Zhiyou Cai
Journal:  J Int Med Res       Date:  2019-06-26       Impact factor: 1.671

9.  Cerebrovascular disease, neurodegeneration, and clinical phenotype in dementia with Lewy bodies.

Authors:  Daniel Ferreira; Zuzana Nedelska; Jonathan Graff-Radford; Scott A Przybelski; Timothy G Lesnick; Christopher G Schwarz; Hugo Botha; Matthew L Senjem; Julie A Fields; David S Knopman; Rodolfo Savica; Tanis J Ferman; Neill R Graff-Radford; Val J Lowe; Clifford R Jack; Ronald C Petersen; Afina W Lemstra; Marleen van de Beek; Frederik Barkhof; Frederic Blanc; Paulo Loureiro de Sousa; Nathalie Philippi; Benjamin Cretin; Catherine Demuynck; Jakub Hort; Ketil Oppedal; Bradley F Boeve; Dag Aarsland; Eric Westman; Kejal Kantarci
Journal:  Neurobiol Aging       Date:  2021-05-14       Impact factor: 5.133

10.  T1-weighted MRI-driven Brain Age Estimation in Alzheimer's Disease and Parkinson's Disease.

Authors:  Iman Beheshti; Shiwangi Mishra; Daichi Sone; Pritee Khanna; Hiroshi Matsuda
Journal:  Aging Dis       Date:  2020-05-09       Impact factor: 6.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.